Stay updated on Factor IX Gene Therapy in Severe Hemophilia B Clinical Trial
Sign up to get notified when there's something new on the Factor IX Gene Therapy in Severe Hemophilia B Clinical Trial page.

Latest updates to the Factor IX Gene Therapy in Severe Hemophilia B Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedAn additional recruitment site in London was added: Guy's & St Thomas' NHS Foundation Trust, St Thomas' Hospital, increasing the total locations to 66. The old 65-location count was replaced, updating the available sites listed for the study.SummaryDifference0.3%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedTwo Swedish site entries were updated to display Malmö (with the proper diacritic) for 205 02 and 211 24, replacing the ASCII Malmo variants.SummaryDifference0.1%

- Check32 days agoChange DetectedThe page’s update metadata was refreshed, including the posted/last-update dates and a site revision version (from v3.5.0 to v3.5.3).SummaryDifference0.1%

- Check54 days agoChange DetectedAdded entries for 2026-04-01 and 2026-04-03, plus a 2026-04 entry; removed entries for 2026-02-28, 2026-02, and 2026-03-16.SummaryDifference0.1%

- Check61 days agoChange DetectedAdded the term 'Hereditary factor IX deficiency disease' and removed 'Hemophilia B' from the page content.SummaryDifference0.0%

- Check68 days agoChange DetectedThe study locations list was expanded with new sites and institutions, bringing the total to 65 locations.SummaryDifference0.7%

Stay in the know with updates to Factor IX Gene Therapy in Severe Hemophilia B Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Factor IX Gene Therapy in Severe Hemophilia B Clinical Trial page.